Cargando…
Ophthalmic Solution of Smart Supramolecular Peptides to Capture Semaphorin 4D against Diabetic Retinopathy
Diabetic retinopathy (DR) is the leading cause of vision loss in working age population. Intravitreal injection of anti‐VEGF antibody is widely used in clinical practice. However, about 27% of patients show poor response to anti‐VEGF therapy and about 50% of these patients continue to have macular t...
Autores principales: | Li, Ya‐Nan, Liang, Hong‐Wen, Zhang, Chun‐Lin, Qiu, Yan‐Mei, Wang, David, Wang, Hai‐Ling, Chen, An‐Qi, Hong, Can‐Dong, Wang, Lei, Wang, Hao, Hu, Bo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9875641/ https://www.ncbi.nlm.nih.gov/pubmed/36437109 http://dx.doi.org/10.1002/advs.202203351 |
Ejemplares similares
-
Ophthalmic Solution of Smart Supramolecular Peptides to Capture Semaphorin 4D against Diabetic Retinopathy (Adv. Sci. 3/2023)
por: Li, Ya‐Nan, et al.
Publicado: (2023) -
Semaphorin-3A protects against neointimal hyperplasia after vascular injury
por: Wu, Jie-hong, et al.
Publicado: (2018) -
Photoresponsive supramolecular coordination polyelectrolyte as smart anticounterfeiting inks
por: Li, Zhiqiang, et al.
Publicado: (2021) -
The semaphorins
por: Yazdani, Umar, et al.
Publicado: (2006) -
Allergy to ophthalmic solutions
por: Lapeere, Hilde, et al.
Publicado: (2014)